Burjeel unveils “Trucheck” blood test for early cancer detection

In a world where cancer too often hides in plain sight, Burjeel Hospitals has rolled out a quiet revolution in diagnostics — Trucheck intelli, a blood test designed to spot cancer before it shows its hand. No scalpels. No scans. Just a few drops of blood. This isn't science fiction; it's the latest leap in preventive oncology, and Burjeel Cancer Institute (BCI) is leading the charge.

How does it work?

Trucheck works on a deceptively simple idea: catching cancer at the microscopic level before it has time to grow roots. The test detects circulating tumor cells (CTCs) and molecular markers that suggest malignancy. Unlike conventional methods relying mainly on circulating tumor DNA (ctDNA), Trucheck focuses on intact tumor cells — giving doctors richer information on morphology and protein expression.

• Detects more than 70 types of solid tumors, including breast, lung, liver, thyroid, and gastrointestinal cancers
• Offers accuracy exceeding 95%
• Requires no fasting or special preparation
• Suitable for anyone over 40 or individuals at high risk due to genetics or family history

As Prof. Humaid Al Shamsi, CEO of Burjeel Cancer Institute, put it: "CTCs might give a more direct signal of malignancy and provide more morphological and protein-level information." In plain terms, it's like reading a full paragraph instead of a single word — the details make all the difference.

Why does it matter?

Early diagnosis in cancer care is like finding the match before it sparks a fire. "Early diagnosis is the cornerstone. It makes a huge difference," Dr. Humaid emphasized. With Trucheck's high precision and speed, doctors can make quicker, more personalized treatment decisions — potentially saving lives and easing both emotional and financial strain on families.

The test also offers something priceless: peace of mind. People can take it once a year, much like a routine check-up, to ensure their body's inner workings stay under watch. The results come fast, the process is painless, and the reassurance could be life-changing.

The context

The global cancer burden is staggering. WHO lists cancer as the second leading cause of death worldwide, a disease that touches nearly every family and every economy. Preventive screening has long been the missing link in catching cancers before they turn lethal.

By launching Trucheck, Burjeel Hospitals is setting a new regional standard for accessible, science-backed preventive care. The approach blends cutting-edge biotechnology with a touch of human foresight — proving that modern medicine isn't just about curing disease, but outsmarting it.